30th Association for Vascular Access (AVA) Annual Scientific Meeting
BETHLEHEM, PA – September 14, 2016 – B. Braun Medical Inc. will sponsor a presentation on peripheral IV catheter stabilization and a CE Symposium on asepsis techniques for ultrasound-guided PIV catheter insertion at this year’s 30th Association for Vascular Access (AVA) Annual Scientific Meeting at Disney’s Coronado Springs Resort in Orlando, Sept. 16-19.
“Realizing the importance of PIV catheter stabilization: Exploring New Concepts” featuring Gregory Schears, MD, will be the Platinum Showcase on Sept. 17 from 5:15 – 6:15 p.m. in the Yucatan room (2-3). This session, sponsored by B. Braun, will provide an overview of current knowledge about catheter stabilization and emerging new concepts. In addition to a literature review, knowledge gaps and remaining clinical problems will be discussed.
For the CE Symposium – “The Great Debate: Insertional Asepsis for Ultrasound Guided PIV Catheters” – a distinguished panel of speakers will discuss how best to insert peripheral catheters with ultrasound: sterile or aseptic no touch. Gregory Schears, MD, Mark Rupp, MD; Nancy Moureau, RN, BSN, CRNI, CPUI, VA-BC; and Rob Dawson, DNP, MSA, APRN, ACNP-BC, CRNI, VA-BC will review relevant literature and practice principles on Sept. 17 from 6:30 – 8:30 p.m., in the Fiesta 6 room. The B. Braun sponsored symposium includes a dinner buffet.
“As a leader in IV therapy, we’re pleased to be able to bring renowned healthcare experts together to discuss current issues and advance clinical PIV knowledge that help to improve outcomes, as well as the quality and efficiency of healthcare delivery,” said Tom Sutton, Vice President of Vascular Access Systems at B. Braun.
B. Braun is also a proud sponsor of AVA Foundation’s annual fundraiser Connect the Dots, which supports education and research.
About B. Braun
B. Braun Medical Inc., a leader in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the healthcare industry. The company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. B. Braun Medical is part of the B. Braun Group of Companies in the U.S., which is headquartered in Bethlehem, Pa., and includes B. Braun Interventional Systems, Aesculap® and CAPS®.
Globally, the B. Braun Group of Companies employs more than 56,000 employees in more than 60 countries. Guided by its Sharing Expertise® philosophy, B. Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs. To learn more about B. Braun Medical, visit www.BBraunUSA.com.